在人类血和尿液基质中开发和验证一种高度灵敏的三元四元LC-MS/MS方法,用于确定贝克西沙林 (LP352)

Raja Reddy Kallem1, Maisy Yeager2, Rosa Chan1

  • 1Department of Clinical Pharmacology and Pharmacometrics, Longboard Pharmaceuticals, Inc. is a part of Lundbeck as a wholly owned subsidiary of Lundbeck LLC, La Jolla, California, USA.

PubMed
概括

一种新的LC-MS/MS方法准确地量化了人体血和尿液中的5-HT2c受体激动剂贝克西沙林. 这种经过验证的方法支持临床开发治疗发育性和性脑病变 (DEE) 中的发作.